Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
RNA
Stock Latest News
Company Announcements
Avidity Biosciences Advances RNA Therapeutics with Strong Q2
12d ago
RNA
Premium
Ratings
Promising Potential of Avidity Biosciences: Buy Rating Affirmed by Ananda Ghosh
17d ago
RNA
Premium
The Fly
Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
20d ago
AZN
BMY
Premium
Ratings
Avidity Biosciences: Strong Buy Rating Backed by Promising Clinical Outcomes and Robust Financial Position
20d ago
RNA
Premium
The Fly
Avidity Biosciences price target raised to $75 from $70 at Wells Fargo
20d ago
RNA
Premium
Ratings
Avidity Biosciences: Promising Pipeline and Strong Financials Justify Buy Rating
20d ago
RNA
Premium
Ratings
Avidity Biosciences: Strong Buy Rating Amidst Promising Muscle Disease Program Developments and Robust Financial Position
20d ago
RNA
Premium
The Fly
Avidity Biosciences price target raised to $62 from $59 at Barclays
20d ago
RNA
Premium
Company Announcements
Avidity Biosciences Signs Manufacturing Agreement with Lonza
21d ago
8K
RNA
Premium
The Fly
Avidity Biosciences reports Q2 EPS ($1.21), consensus (96c)
21d ago
RNA
Premium
Ratings
Avidity Biosciences: Promising Pipeline and Strategic Developments Drive Buy Rating Amid Potential Novartis Takeover Interest
21d ago
RNA
Premium
The Fly
Disney reports Q3 beat and NFL deal, Uber authorizes $20B buyback: Morning Buzz
22d ago
U
GO
Premium
The Fly
Avidity up over 20% to $46.05 after FT report of buyout interest
22d ago
RNA
Premium
The Fly
Novo Nordisk made takeover approach to Avidity Biosciences, FT reports
22d ago
NVO
RNA
Premium
The Fly
Avidity jumps 3% to $39.47 after FT report of takeover approach
22d ago
RNA
Premium
The Fly
Avidity Biosciences trading resumes
22d ago
RNA
Premium
The Fly
Novartis makes takeover approach for Avidity Biosciences, FT reports
22d ago
NVS
RNA
Premium
The Fly
Avidity Biosciences trading halted, volatility trading pause
22d ago
RNA
Premium
Company Announcements
Avidity Biosciences’ Phase 3 Study Update: Del-desiran for Myotonic Dystrophy
29d ago
RNA
Premium
The Fly
Avidity Biosciences completes enrollment in Phase 3 HARBOR clinical trial
1M ago
RNA
Premium
Company Announcements
Avidity Biosciences Gains FDA Breakthrough Therapy Designation
1M ago
8K
RNA
Premium
The Fly
Avidity Biosciences receives FDA BTD for delpacibart zotadirsen
1M ago
RNA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.